Human ribosomal protein L23 (RPL23), a classical RBP, has been reported to be involved in a variety of human cancers including lung cancer (23), myelodysplastic syndromes (11), gastric cancer (24), and colorectal cancer (25). This evidence concerns the gene RPL23 and myelodysplastic syndrome.